The FDA has approved datopotamab deruxtecan (Dato-DXd, Datroway, Daiichi Sankyo) for the treatment of patients with ...

Dr Sunnie Kim previews key GI trials highlighting novel bispecific antibodies, dual immunotherapy combinations, KIT ...

Insomnia, sleepiness, fatigue, and stress were associated with higher depression scores, but caffeine appeared to lessen the ...

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than ...

Insights from ASCO 2026, including anticipated presentations, key takeaways, and how emerging research in GI cancers may affect patient care.

A cohort study of births in Brazil found increased hospitalization risk through age 3 after maternal chikungunya; results ...

An early evaluation of 'Swap to Stop' scheme in England shows a 4-week quit rate of 34.3% among recipients of free ...

Novel CRISPR-Cas9 treatments are proving effective in reversing disease for life. But ensuring their long-term safety will ...

The conditional authorization covers adults and children aged 2 years and older with severe or life-threatening ...

Researchers have identified a compound produced by a variety of land snail that prevents blood clots without prolonging ...

Higher dermatologist density is associated with lower proportions of late stage melanoma diagnosis across US health service ...

The use of potassium-competitive acid blockers is not linked to an increased risk for C difficile infection compared with the use of other acid-suppressive agents.